The honest bottom line: tirzepatide has a slight edge in clinical effectiveness, semaglutide has a longer track record and often better coverage, and oral pills now offer a needle-free alternative
Hims & Hers projects 2024 revenue to hit $1.37B buoyed by demand for weight loss drugs, Fierce Healthcare, August 6, 2024
Every treatment plan is based on FDA-approved therapies, individualized evaluation, and a clear understanding of the patients goals and medical needs
Frequently Asked Questions Which conditions rule semaglutide out completely
GLP-1 type medications mimic a natural hormone called GLP-1 (glucagon-like peptide-1) which regulates appetite and food intake
Thats why some providers recommend staying on the medication longer than just until the scale hits a target number